Drug monitoring of argatroban using the ecarin chromogenic assay

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue SUPPL. 1, 2008, Pages 81-86

  Nowak, Götz ^a   Lange, Ute ^b   Bucha, Elke ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b SIRS Lab GmbH   (Germany)

Author keywords

Argatroban; Direct thrombin inhibitor; ECA; ECA T; Ecarin chromogenic assay; Monitoring

Indexed keywords

ARGATROBAN; CHROMOGENIC SUBSTRATE; ECARIN; HEPARIN; MEIZOTHROMBIN; PROTHROMBIN;

BLOOD CLOTTING TIME; CONFERENCE PAPER; DRUG MONITORING; DRUG SAFETY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 57349143273     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0028-1086086     Document Type: Conference Paper

References (3)

1. Nowak G, Bucha E. Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost 1996;22:197-202
2. Lange U, Nowak G, Bucha E. Ecarin chromogenic assay: a new method for quantitative determination of direct thrombin inhibitors like hirudin. Pathophysiol Haemost Thromb 2003/04;33:184-191
3. Lange U, Olschewski A, Nowak G, Bucha E. Ecarin chromogenic assay. Hamostaseologie 2005;25:293-300